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Background: To understand the role of proteases involved in human thyroid cancer progression and tissue
invasion, thyrocytes from other species could potentially be used provided their characteristics are similar. It is not
known whether dipeptidyl peptidase IV and aminopeptidase N activities, which are overexpressed in human thyroid
cancer, are, as in human, also absent in normal thyrocytes of other species, making them suitable models for
studies on the regulation of these proteases.
Methods: To assess the role of these proteases, activity was measured in thyroid tissue of human, mouse, rat,
porcine, bovine and ovine origin. The lysosomal protease, dipeptidyl peptidase II, was used for comparison.
Results: Murine, rat, ovine, bovine and human thyrocytes all lacked dipeptidyl peptidase IV and aminopeptidase N
activity, but porcine thyrocytes were found to possess both. In contrast, lysosomal dipeptidyl peptidase II was
strongly expressed in all species. These activity patterns were maintained in cultured cells. Cultured porcine
thyrocytes formed follicles with typical morphology upon stimulation with TSH but differed from human thyrocytes
in their response to thiamazole.
Conclusions: These species differences in the expression of dipeptidyl peptidase IV and aminopeptidase N, indicate
that porcine thyrocytes cannot be considered appropriate for the study of proteases in human cancer
development.
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Normal thyrocytes are used for investigations of hormone
synthesis, regulation of proliferation and differentiation
and as controls in drug screening. Primary cells and cell
lines of canine, porcine, bovine, ovine and rat origin are
used to address different questions. Rat cell lines, espe-
cially the FRTL5 line, are used for proliferation studies [1],
whereas porcine and bovine cells are used most com-
monly for differentiation and gene expression studies.
Similar to ovine thyrocytes, cells from these species show
a poor response to TSH and, therefore, are not suited for
studies of proliferation [2]. Due to their limited availability,
very few groups use canine thyrocytes for their studies.* Correspondence: richard.wahl@med.uni-tuebingen.de
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reproduction in any medium, provided the orDespite conserved physiology, marked differences between
these species have already been reported [3,4]. Stimulation
with TSH and insulin triggers DNA synthesis in dog thyro-
cytes and rat cell lines by very different mechanisms.
Interspecies differences in the regulation of protease ac-
tivities are of particular importance because several lyso-
somal and membrane-associated proteases promote tumor
development and progression. The lysosomal enzymes
cathepsin B and cathepsin L are over-expressed in thyroid
cancer as in most other cancers [5,6]. Similar to other
cancers, the participation of metalloproteinases, especially
metalloproteinases (MMP) MMP-2, also termed type IV
collagenase, in thyroid cancer progression has also been
confirmed [7-9]. Additionally, the urokinase-type plasmino-
gen activator is involved in the progression of thyroid can-
cer by remodelling the extracellular matrix [5,10]. Increases
in transmembrane proteases such as aminopeptidase Nl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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specific to thyroid carcinoma [11,12]. DPP IV activity is
increased in some cancer types (e.g. thyroid cancer, prostate
cancer, [13,14] and decreased or lost in others (e.g.
melanoma, [15,16]). DPP IV regulates contact inhibition,
cell cycle, morphological differentiation, tissue inhibitors of
metalloproteinases, anchorage-dependent growth and E-
cadherin of epithelial cancers [17]. A presumed role of DPP
IV in cancer is in the induction of metabolic changes creat-
ing a favourable climate for the development of the tumor
[17]. As DPP IV is occasionally expressed in thyrocytes of
benign thyroid disorders [18] a link to proliferation has
been suggested [11]. Increased APN expression is corre-
lated with progression and metastasis in colorectal, pancre-
atic carcinoma and undifferentiated thyroid carcinoma
[12,19,20].
Dipeptidyl peptidase II (DPP II, EC 3.4.14.2), a lysosomal
protease ubiquitously expressed in many cells including
normal thyrocytes of mammalian origin [21], is thought to
play a role in the release of hormone from thyroglobulin
[22].
Dipeptidyl peptidase IV (DPP IV, CD26, EC 3.4.14.5) is a
trans-membrane type II glycoprotein with multifaceted
function. As well as the integral membrane form, a soluble
form is found in serum and semen. In contrast to thyroid
follicle cells, most other types of human cell express DPP
IV [23]. DPP IV is most up-regulated in papillary thyroid
carcinoma [24,25] and apparently induced by RET/PTC
mutations [26].
Aminopeptidase N (APN, aminopeptidase M, alanine
aminopeptidase, CD13, EC 3.4.11.2), is expressed in ana-
plastic thyroid carcinoma cells but not in normal thyrocytes
[12]. In porcine thyrocytes, by contrast, APN is a marker of
the apical thyrocyte membrane [27,28].
To identify species with an identical pattern of pro-
tease activity compared to human thyrocytes, here we
localized protease activities using synthetic substrates.
The activities of DPP II, DPP IV and APN were stud-
ied in animal species used for investigating thyroid




Cadavers of rats (female, Sprague–Dawley) and mice
(female, Balb/c), which had been used for other experi-
ments, were obtained from the Institute of Pharmacology
and the Institute of Anatomy, respectively. Porcine, bovine
and ovine thyroid glands were obtained from the local
slaughterhouse. Samples from human thyroid tissue were
obtained from the surgical department of the University
after informed consent of the patients. Animal procedures
were performed according to the guidelines of the local
authorities. All experiments on human subjects wereconducted in accordance with the Helsinki Declaration of
1975.
For the localization of DPP IV and APN activities
unfixed tissues were used. For the demonstration of DPP
II 0.5 cm3 cubes of thyroid tissue were fixed in neutral
buffered 4% formaldehyde solution with 30% sucrose for
24h at RT. After fixation, samples were rinsed for 24h at
RT in distilled water containing 30% sucrose and 1%
gum arabicum. Tissue samples were embedded in Tissue
Tec (Miles) and deep-frozen in isopentane per-cooled
with liquid nitrogen.
Detection of protease activity
Protease activity in tissues and in cells was detected by
cleavage of specific synthetic substrates. The synthetic
substrate is bound to a tag, which together with the
coupler yields a colored product, when released from
the substrate.
Substrates coupled to 4-methoxy-2-naphthylamide
(MNA, Bachem Ltd.) were used at a concentration of 0.5
mg/ml. Visualization of the reaction product was achieved
through the presence of 1 mg/ml Fast Blue B (FFB, pure,
tetrazotized Di-2-anisidine ZnCl2, Serva) in the reaction
mixture.
10 μm cryostat sections were pre-treated with an ice-cold
mixture of acetone and chloroform (1:1) for 5 min. Slides
were air-dried for 30 min at RT prior to the incubation with
the substrate solution.
The following substrates were used: Gly-Pro-MNA in 0.1
M PBS pH 7.0 for DPP IV, Ala-MNA in 0.1M PBS pH 7.0
for APN and Lys-Ala-MNA in 0.1 M cacodylate buffer pH
5.5 for DPP II [29]. Incubation time was 30 min for APN
and DPP IV and 60 min for DPP II at 37°C. After washing
in bi-distilled water slides were mounted with Kaiser's gly-
cerol gelatine (Merck). Some sections were counterstained
with hemalaun. For controls, the group-specific inhibitors
(1 mM phenylmethanesulfonylfluoride and 1 mM diisopro-
pylfluorophosphate, Sigma for DPP II and DPP IV and 10
mM 1,10-phenanthroline, Serva) were included in the incu-
bation mixture.
Physiological characterization of thyrocytes
Cell culture
Primary culture of porcine thyrocytes was performed as
described previously [30]. In brief, connective tissue was
removed from thyroids of 10–20 pigs and thyroid glands
were dissected into pieces of 0.5 - 1 cm3. The pieces were
incubated with 1 l 0.5% dispase II (Roche) in Earle’s salt
solution (Gibco) for 2h at 35°C. The incubation solution
was constantly stirred and aliquots of 150 ml were taken
and sieved through a tea sieve. The cell suspensions were
diluted 1:3 with Earle’s solution and centrifuged (200 g for
7 min at 4°C). Cells were cultured in 6-well culture plates
(FalconW) at a density of 3x106 cells/well in NCTC-135
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and 1 μg/ml hydrocortisone and antibiotics. Human thyro-
cytes were also isolated from euthyroid goiters using the
same protocol. 1 mU/ml porcine TSH (Sigma-Aldrich) was
added to induce the formation of follicles. Cells were also
cultured in the absence of TSH.
Cell number and cell viability were determined in an
automatic mode based on the electrical sensing zone
method (CASY Technology).
For the localization of protease activities, cells (1.5x106)
were seeded on cover slips placed at the bottom of 6-well
plates. After 48 h of incubation, cover slips were either fixed
in neutral buffered 4% formaldehyde solution with 30%
sucrose for 10 min at RT, rinsed in PBS and infiltrated for
30 min at RT in distilled water containing 30% sucrose and
1% gum arabicum or placed immediately into an ice-cold
mixture of acetone and chloroform (1:1) for 5 min and then
stored at −20°C until assayed for protease detection (see
above).
Iodide uptake
For iodide uptake, 2.6 x105 cells/well were plated in 48-
well plates (CostarW) and treated with either 1.3 mU/ml
TSH (Sigma) alone or TSH in combination with 2 mM
thiamazole (FavistanW, Temmler Pharma) or 1 mM
sodium perchlorate (99.9%, VWR International). Four
kBq/well carrier-free Na125I (Amersham Biosciences) was
added 6h prior to the measurement. Control cells were
cultured in the absence of TSH. Cells were collected after
24h and 30 h of incubation and washed with a 48-well cell
harvester (IH110, Inotech) with 1 μM NaI included in the
washing solution. Filtermats (type 11731, Skatron) were
transferred to counting tubes and measured (1480 auto-
matic Gamma counter, Wallac).
The Dunnett test was used for statistical analysis. Results
were considered statistically significant when p< 0.05.
Mean ± SEM of n=4 experiments.
Ultrastructural analysis
Cells were cultured on gas-permeable hydrophilic poly-
fluoroethylene membranes (Petriperm, Heraeus) and fixed
for 2h in 2.5% glutaraldehyde in 0.05 M cacodylate buffer
pH 7.4 containing 2% sucrose, washed and post-fixed in 1%
aqueous osmium tetroxide in 0.2 M buffer for 2h. Samples
were dehydrated and embedded in Epon. Sections were
cut, stained with saturated aqueous uranyl acetate (20 min)
and lead citrate (5 min) and viewed with a LEO 912
OMEGA (Zeiss) transmission electron microscope.
Results
Protease activities in thyroid tissue
Because not all samples were collected at the same time,
and the period between collection and freezing varied
between 1h and 2.5h, time-dependent changes in thestaining intensities were investigated over 4h in porcine
thyroids. Despite a slight decrease of the staining inten-
sity over this time, no loss of stained structures was
observed. Perifollicular cells, which express all tested
protease activities, served as controls that protease activ-
ities could be detected in the tissue.
Activity of DPP II was detected in mouse, rat, human
sheep, pig and cow thyrocytes (porcine and bovine thyroid
shown, Figure 1 a, b). Activity of DPP IV and APN was
absent in all these species (eg. bovine thyroid, Figure 1d)
except porcine (Figure 1c). In all species, endothelial cells
stained for APN activity and occasionally also for DPP IV
activity. In porcine thyrocytes some, but not all, follicular
thyrocytes displayed DPP IV activity (Figure 1c). Activity
was localized in the cytoplasm and at the apical membrane.
Porcine thyrocytes also showed strong APN activity at
the apical pole of the cell (Figure 1e). In addition to thyro-
cytes, also endothelial cells weakly expressed APN activity.
In the other species studied, APN activity was restricted to
endothelial cells in the peritumoral stroma (Figure 1f).
Morphology, iodide uptake and protease activities in
cultured thyrocytes
In human thyrocytes, only DPP II but no activities for
APN and DPP IV were detected, suggesting that the iso-
lation from the tissue did not cause prominent changes
in the pattern of protease activities. To determine
whether isolated cultured porcine thyrocytes also
behaved similarly to thyrocytes in intact tissue, these
cells were physiologically characterized.
Porcine thyrocytes formed functional follicles with char-
acteristic thyrocyte morphology and with a stable preserved
polarity in the presence of TSH (right-side-right follicles,
Figure 2a). at the apical surface and tight junctions between
the cells, but no basement membrane formed at the basal
pole of the cells.
Upon stimulation with TSH, iodide uptake was increased
by a factor of 6.8 relative to unstimulated controls
(Figure 2b). This uptake was inhibited by 1mM perchlorate.
Despite being an inhibitor of iodine organification, not of
iodide uptake, thiamazole also significantly decreased
iodide-uptake.
Activities for all enzymes detected in intact tissues were
also demonstrated in primary cultures of porcine thyrocytes
when cultured in the presence of TSH. Intracellular
localization of DPP II was seen in all cells (Figure 2c), but
only thyrocytes integrated into follicles showed localization
of APN at the plasma membrane (Figure 2d). Compared to
APN, DPP IV activity was very weak. When cultured in the
absence of TSH in porcine thyrocytes only DPP II could be
detected (data not shown), whereas the activities of APN
and DPP IV were below the detection threshold. In human
thyrocytes, only DPP II activity, but not APN and DPP IV
was detected.
Figure 1 Detection of protease activity with synthetic substrates by histochemistry (red) in porcine (a, c) and bovine (b, d) thyroid
tissue. Activities of perifollicular cells (endothelial cells, fibroblasts and C-cells) for the respective proteases are indicated by arrowheads. a, b:
Activity of dipeptidyl peptidase II is seen intracellularly in thyrocytes of both species. c: In porcine thyroids activity of dipeptidyl peptidase IV is
seen in some follicle cells. d: In bovine thyroids, follicle cells show no activity for dipeptidyl peptidase IV substrate. e: Activity of aminopeptidase
N is seen at the apical part of the cells in porcine follicular thyrocytes (arrow), whereas in bovine thyroids (f) activity of aminopeptidase N is
restricted to endothelial cells the perifollicular stroma below the follicular epithelium (arrowhead). FL: follicle lumen.
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We report differences in the activities of two membrane-
associated proteases, DPP IV and APN, between thyrocytes
from human and animal sources. These differences may
reflect profound differences in the regulation of some pro-
teases between human and porcine thyrocytes because the
expression of DPP IV and APN is linked to transformation
of human thyrocytes.
Thyrocytes from animals play an important role in the
study of physiological processes because inter-individual
variations in animals usually are lower than in humans.
Inter-individual variations in protein expression, iodide up-
take, proliferation and other physiological reactions are
more pronounced in normal human thyroid tissue samples
and isolated human thyrocytes than in porcine ones [31].
Causes of different physiological reactions among indivi-
duals include genetic factors and environmental factors
(dietary iodine, smoking, infections, etc.). Due to these
limitations, porcine, bovine, ovine and canine thyrocytes
are common substitutes for normal human cells because
only animal thyrocyte lines able to form follicles and
synthesize thyroid hormones are available [1,32]. Despite
general similarities in morphology, synthesis of thyroidhormone and the reaction to TSH, several differences
between the species, including molecular differences in
proteins, in expression and in reaction to growth factors,
have been identified [2,33-36].
In our study, lysosomal protease activity of DPP II was
strongly expressed in thyrocytes of all species. This lack of
interspecies differences was also reported in another study
on the expression pattern of the lysosomal proteases
cathepsin B and elastase in the placenta of mice, rats,
guinea pigs and marmosets [37]. In contrast, we saw ex-
pression of DPP IV and APN only in porcine thyrocytes
but not in thyrocytes from other species. In human thy-
roid glands, consistent with previous studies, thyrocytes
lacked both enzyme activities and only endothelial cells
showed reactivity for DPP IV [38]. Pronounced inter-
species variations in the expression of the membrane-
associated proteases were also reported by Gossrau and
Graf, who investigated cellular expression of γ-glutamyl-
transpeptidase, aminopeptidase A, APN and DPP IV activ-
ities [37].
The observed differences in protease activities persisted
in cultured porcine cells when cultured in the presence of
TSH. As the membrane-associated proteases DPP IV and
Figure 2 Physiological behaviour of cultured porcine thyrocytes according to ultrastructure, iodide uptake and protease activity
detected by synthetic substrate (red). a: Porcine thyrocytes form follicles with formation of apical microvilli and intercellular tight junctions
when stimulated with 1.3 mU/ml TSH for 30h. b: Upon stimulation with TSH, iodide uptake of thyrocytes is increased 6.8 times compared to
unstimulated cells (mean ± SEM is shown). TSH-induced iodide uptake is inhibited by 1 mM perchlorate and significantly reduced upon exposure
to TSH + 2 mM thiamazole (p< 0.05). c: Upon stimulation with TSH for 30h, DPP II activity is seen in all cells, whereas activity of APN at the
plasma membrane in seen only in thyrocytes integrated in follicles but not in isolated cells (d, arrowhead). N: nucleus, FL: follicular lumen.
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expressed when follicles are formed. This indicates that,
contrary to human thyrocytes, they are markers of differen-
tiation, not de-differentiation. Expression of APN in por-
cine thyrocytes has also been reported by Feracci et al. [27].
Because of these observed differences, porcine thyrocytes
are not suitable models for studies on the regulation of
membrane-protease in human thyrocytes.
The determination of actual protease activity in this
study, instead of merely detecting protein or mRNA, allows
a direct assessment of relevant functional activity. Protease
activity is regulated at different levels, including alternative
splicing, compartmentalization, pH, aggregation of sub-
units, inhibitors etc. [39,40] and often a correlation between
mRNA expression and protease activity is lacking [41].
Nevertheless, absence of mRNA does indicate absence of
the protein and is, therefore, useful because a lack of cross-
reactivity of the available antibodies hinders interspecies
comparisons.
One problem in the evaluation of protease activity by
synthetic substrates may be the lack of specificity of
these peptides. Although different proteases degrade
similar substrates in vivo, the choice of the fixation,
evaluation of the staining by microscopy as well as the
inclusion of appropriate inhibitors makes false positiveresults in this study highly unlikely. Peptides with pro-
line in the penultimate position at the amine terminus
are only cleaved by DPP IV and its homologues [42].
APN selectively cleaves peptides with alanine in the pen-
ultimate position. Activities of DPP IV and APN are
inhibited almost completely by inclusion of diisopropyl
fluorophosphate and 1,l0-phenanthroline, respectively
[43], showing that under the conditions used, the stain-
ing is specific. Differentiation between proteases with
similar substrate specificity and catalytic centers, for in-
stance DPP II and DPP IV, can be achieved by using the
appropriate fixation protocols [44].
We also showed here that differences between porcine
and human thyrocytes are not restricted to the expression
of protease activities. Although porcine thyrocytes re-orga-
nized into follicle-like structures similar to those seen in
human, the TSH-induced increase in iodide uptake was
slightly smaller than reported for human cells (7–10 times,
[45,46]). More importantly, the reaction to thiamazole dif-
fered between porcine and human thyrocytes. Whereas
these inhibitors of iodide organification have no effect
on iodide uptake in cultured human thyrocytes [47],
they depressed iodide uptake in our study (porcine
thyrocytes) as well as in studies on canine thyro-
cytes [48,49].
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The presented data show that expression of membrane-
associated proteases in thyrocytes is subject to inter-species
variations. Although thyrocytes from animals are useful
tools for the investigation of human thyrocytes, for studying
protease changes porcine thyrocytes appear to be less
suited than thyrocytes from other species.
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